Piramal Enterprises (Delisted) share news and announcements

BSE: 500302Finance

Formerly Piramal Healthcare

Last traded ₹1,124.20 on 22 Sep 2025

Delisted on 16 Jan 2026.

Piramal Enterprises share news and announcements

3,280 announcements, routine notices left out, newest first. Page 66 of 66.

  1. Oct 2007

    • 25 Oct · Business

      Nicholas Piramal India Ltd. has informed the Exchange regarding a press release dated October 25, 2007, titled "Nicholas Piramal reports Q2 FY2008 results; Total Revenues grow 17% to Rs.7.6 billion, Net Profit up by 58% to Rs.847.4 million". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

    • 25 Oct · Results

      Nicholas Piramal India Ltd. has informed the Exchange regarding the consolidated Results for the quarter ended on 30-SEP-2007 as follows: Net Sales of Rs. 76457 lacs for quarter ending on 30-SEP-2007 against Rs. 65466 lacs for the quarter ending on 30-SEP-2006. Net Profit / (Loss) of Rs. 8477 lacs for the quarter ending on 30-SEP-2007 against Rs. 5369 lacs for the quarter ending on 30-SEP-2006.

    • 25 Oct · Results

      Nicholas Piramal India Ltd. has informed the Exchange regarding the standalone Results for the half year ended on 30-SEP-2007 as follows: Net Sales of Rs. 92684 lacs for half year ending on 30-SEP-2007 against Rs. 84331 lacs for the half year ending on 30-SEP-2006. Net Profit / (Loss) of Rs. 11537 lacs for the half year ending on 30-SEP-2007 against Rs. 11806 lacs for the half year ending on 30-SEP-2006.

    • 17 Oct · Board meeting

      To consider and take on record the Audited Financial Results of NPIL and the Unaudited Consolidated Financial Results for the 2nd Quarter and half-year ended September 30, 2007.

    • 5 Oct · Business

      Nicholas Piramal India Ltd. has informed the Exchange vide their letter dated October 05, 2007, that: "The duly authorised Committee of Directors have today approved the merger of the Company's wholly-owned subsidiary, NPIL Healthcare Pvt. Ltd. with the Company".

  2. Sep 2007

    • 5 Sep · Management

      Nicholas Piramal India Ltd. has informed the Exchange vide its letter dated September 04, 2007 that "Mr. Michael J. Fernandes-Executive Director (CMG) has resigned from the services of the Company for personal reasons".

  3. Aug 2007

    • 31 Aug · Business

      Nicholas Piramal India Ltd. has informed the Exchange vide its letter dated August 31, 2007, that: "The Board of Directors at its Meeting held today, approved the proposal of de-merging its New Chemical Entity (NCE) Research Unit under a Scheme of Arrangement into a separate company (Transferee Company) in which Nicholas Piramal India Limited (NPIL) will hold equity capital of Rs.5 crores. Under the proposed Demerger Scheme, the NCE Undertaking with net assets (at book value) inclusive of unutilized monies collected under the Rights Issue of 2005 and intended for R&D to the extent of Rs. 95 crores would be transferred from NPIL to the Transferee Company, with effect from 1st April 2007, which is the Appointed Date under the Scheme. In consideration, the Transferee Company would issue fully paid up equity shares aggregating to Rs.21 Crs to the shareholders of NPIL in the ratio of 1:10 (i.e. 1 equity share of Rs.10 for every 10 equity shares of Rs.2 each held in NPIL). Post de-merger, NPIL would hold 18% of the equity capital of the Transferee Company and the remaining 82% would be held by the shareholders of NPIL and thus, the Transferee Company would be an independent company. The Transferee Company would be listed on the BSE and NSE and after listing, at an appropriate time, will explore various options for raising further funds to meet its business requirements. The above Scheme is subject to applicable regulatory and other approvals". Further, a copy of the press release in this regard dated August 31, 2007, titled "Nicholas Piramal to de-merge its New Chemical Entity (NCE) Research and Development unit into an independent company" shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

    • 27 Aug · Board meeting

      To consider a proposal for restructuring the Company's R&D Division by de-merging its New Chemical Entity (NCE) Research Unit into a separate entity under a Scheme of Arrangement.

  4. Jul 2007

    • 25 Jul · Business

      Nicholas Piramal India Ltd. has informed the Exchange on July 25, 2007 that "The Board has also today approved a proposal for merger of the Company's wholly owned subsidiary, Nicholas Piramal Consumer Products Pvt. Ltd.(formerly known as Boots Piramal Healthcare Pvt. Ltd.) with the Company".

    • 25 Jul · Business

      Nicholas Piramal India Ltd. has informed the Exchange regarding a press release dated July 25, 2007, titled "Nicholas Piramal reports Q1 FY2008 results; Total Revenues increased 16.4% to Rs.6.1 billion, Net Profit was lower by 19.4% to Rs.434.3 million". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

    • 25 Jul · Results

      Nicholas Piramal India Ltd. has informed the Exchange regarding the consolidated Results for the quarter ended on 30-JUN-2007 as follows: Net Sales of Rs. 60807 lacs for quarter ending on 30-JUN-2007 against Rs. 52257 lacs for the quarter ending on 30-JUN-2006. Net Profit / (Loss) of Rs. 4373 lacs for the quarter ending on 30-JUN-2007 against Rs. 5386 lacs for the quarter ending on 30-JUN-2006.

    • 25 Jul · Results

      Nicholas Piramal India Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 30-JUN-2007 as follows: Net Sales of Rs. 39502 lacs for quarter ending on 30-JUN-2007 against Rs. 40152 lacs for the quarter ending on 30-JUN-2006. Net Profit / (Loss) of Rs. 3439 lacs for the quarter ending on 30-JUN-2007 against Rs. 5100 lacs for the quarter ending on 30-JUN-2006.

    • 23 Jul · Business

      Nicholas Piramal India Ltd. has informed the Exchange regarding a press release dated July 23, 2007, titled "Nicholas Piramal India Limited's IND-P276- a new drug discovery from Mumbai, India has been approved by USFDA". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

    • 17 Jul · Board meeting

      To consider and take on record the Financial Results of the Company (consolidated and stand-alone) for the 1st Quarter ended June 30, 2007.

  5. Jun 2007

    • 18 Jun · Meeting

      Nicholas Piramal India Ltd. has informed the Exchange that at the AGM of the Company held on June 14, 2007, all the businesses mentioned in the Notice convening the said meeting were transacted and all the resolutions were passed unanimously. A brief summary of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

    • 13 Jun · Meeting

      Nicholas Piramal India Ltd. has submitted to the Exchange a copy of the Notice of Annual General Meeting of the Company scheduled to be held on June 14, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

  6. Apr 2007

    • 26 Apr · Meeting

      Nicholas Piramal India Ltd. has informed the Exchange that the Board Meeting held today (i.e. April 26, 2007) the Board has declared final Equity Dividend at 25% (i.e. Rs.0.50 per share) on 20,90,17,606 equity shares of Rs.2/- each. This is in addition to the interim Equity dividend at 150% (i.e. Rs.3 per equity share of Rs.2/ each) which was declared by the Board on March 15, 2007. Thus, total Equity Dividend for the financial year ended March 31, 2007 works out to 175% (i.e. Rs.3.50 per share). As regards dividend on Preference Shares, the entire preference dividend was declared and paid as interim dividend during the financial year ended March 31, 2007. The Baord has also fixed the date for the Annual General Meeting (AGM) of the Company on June 14, 2007. The Register of Members and shares Transfer Books shall remain closed from June 04, 2007 to June 14, 2007 (both days inclusive), for the purpose of declaration of final equity dividend of 25% i.e. Rs.0.50 per equity share as aforesaid.

    • 26 Apr · Business

      Nicholas Piramal India Ltd. has informed the Exchange regarding a press release, dated April 26, 2007, titled "Nicholas Piramal reports Q4 FY2007 results; Consolidated Revenues up 51.7% to Rs. 6.4 billion, Operating Profit up 137.9% to Rs. 848.9 million, Net Profit up 262.2% to Rs 549.5 million." A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

    • 17 Apr · Board meeting

      To consider and approve the Audited Financial results of the Company (stand-alone and consolidated) for the financial year ended March 31, 2007.

  7. Mar 2007

    • 15 Mar · Dividend

      Nicholas Piramal India Ltd. has informed the Exchange on March 15, 2007 that: "The Board has today declared Interim Equity Dividend @ 150% (i.e. Rs.3 per share) on 20,90,17,606 Equity Shares of Rs.2 each. The Board has also declared interim Dividend on the following Preference Shares: a) @ 5% on 15,00,000 - 5% Cumulative Redeemable Preference Shares of Rs.100/- each; b) @ 5% on 2,33,72,280 - 5% Cumulative Redeemable Preference Shares of Rs.10/- each. The above Interim Dividends would be paid to those members whose names appear on the Company's Register of Members (in case of shares held in physical form) or as Beneficial Owners as per list furnished by the Depositories (in case of shares held in demat form) as on 26th March 2007, which is the Record Date that has been fixed for the purpose".

    • 14 Mar · Results

      Nicholas Piramal India Ltd. has submitted to the Exchange a copy of the Results on Voting by Postal Ballot. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

    • 8 Mar · Board meeting

      Proposal for declaration of Interim Dividend on the equity and preference shares of the Company for the financial year ending March 31, 2007, is being considered by the Board by way of Circular Resolution for decision as of March 15, 2007. Further the Company has informed the Exchange that in event of the Board declaring Interim Dividend as aforesaid, the Record date for ascertaining the entitlement of the equity and preference shareholders to the said Interim Dividend will be March 26, 2007. Further the Company has informed the Exchange that March 30, 2007 would be the Dividend Payment Date for the said Interim Dividend, if declared by the Board.

  8. Feb 2007

    • 15 Feb · Business

      Nicholas Piramal India Ltd. has informed the Exchange regarding a press release that was issued by the Custom Manufacturing Business Division [NPIL Pharma] at the Informex USA Specialities / Pharma Services Trade Show in San Francisco, USA last night. The Press Release provides details regarding certain development in formulation capabilities and growth plans of NPIL Pharma. The press release dated February 14, 2007, titled "Formulation capabilities to leverage NPIL Pharma growth" shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

    • 14 Feb · Meeting

      Nicholas Piramal India Ltd. has informed the Exchange that pursuant to Section 192A of the Companies Act, 1956 ('the Act') read with the Companies (Passing of the Resolution by Postal Ballot) Rules 2001, the following resolutions seeking shareholders consent are proposed to be passed as Special Resolutions, by way of Postal Ballot: 1) Special Resolution for re-appointment of and payment of remuneration to Mr. Ajay G. Piramal, as Chairman of the Company, for a further period of 5 years with effect from April 01,2007. 2) Special Resolution seeking consent to the Employees Stock Ownership Plan 2006 and for granting Stock Options to Employees of the Company and its subsidiaries thereunder. 3) Special Resolution for variation in the terms of Stock Options granted for the financial year ended March 31,2006. Mr. N.L. Bhatia, a senior Company Secretary practicing since 1982, has been appointed as Scrutinizer for conducting the postal ballot process. The duly completed postal ballot form should reach the Scrutinizer not later than the close of working hours on March 07,2007. The results of the Postal Ballot will be announced by the Chairman or in his absence by a Director of the Company or by any senior officer of the Company duly authorized by the Chairman, on March 14,2007. The details of the Postal Ballot shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

  9. Jan 2007

    • 30 Jan · Meeting

      Nicholas Piramal India Ltd. has informed the Exchange that: "The Company is seeking shareholders approval, through Postal Ballot, for the following proposals: a) For re-appointment of and payment of remuneration to Mr. Ajay G. Piramal, Chairman of the Company, for a further period of 5 years w.e.f. 1st April, 2007; b) For introducing and implementing a new ESOP Scheme called Employee Stock Ownership Plan 2006 and for granting Stock Options to employees / directors of the Company and its subsidiaries under this Scheme; c) For variation in the terms of Stock Options that were granted to employees for the financial year ended 31st March 2006. With regard to the ESOP proposals referred to in (b) and (c) above, it may be noted that the shares granted by the ESOP Trust (through which the NPIL ESOP Scheme is implemented) against exercise of Stock Options, are not new shares issued by the Company but those that were acquired by the ESOP Trust from existing shareholders. Hence, there will not be any increase in the share capital of the Company, nor will there be any accounting or other impact on the Earnings Per Share or other ratios relating to share capital as a result of such exercise of Stock Options".

    • 22 Jan · Business

      Nicholas Piramal India Ltd. has informed the Exchange regarding a press release, dated January 22, 2007, titled "Napo Enters Plant Screening Agreement with Nicholas Piramal India Limited for Diabetes ." The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

    • 18 Jan · Business

      Nicholas Piramal India Ltd. has informed the Exchange regarding a press release dated January 18,2007, titled "Nicholas Piramal reports Q3 FY 2007 results; Consolidated Revenues up by 60.1% to Rs. 6.5 billion, Operating Profit up by 185.3% to Rs. 970.4 million, Net Profit up by 473.9% to Rs. 555.5 million". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

    • 12 Jan · Business

      Nicholas Piramal India Ltd. has informed the Exchange regarding a press release dated January 12, 2007 titled "Nicholas Piramal announces Drug Development Agreement with Eli and Company - Collaboration Represents a New Clinical Development Model". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.

    • 10 Jan · Board meeting

      To consider and take on record the Audited Financial Results of the NPIL and the Unaudited Consolidated Results for the 3rd Quarter ended 31st December, 2006.

    • 4 Jan · Business

      Nicholas Piramal India Ltd. has informed the Exchange that "Wellspring, the chain of Pathology Laboratories and Diagnostic Centres promoted by Nicholas Piramal India Ltd (NPIL), has acquired Jankharia Imaging, the most successful radiology and imaging centre in Mumbai. The new entity would be renamed as Wellspring Jankharia Imaging. The acquisition has been done by NPIL's wholly-owned subsidiary NPIL Laboratories & Diagnostics Pvt. Ltd. The Company also submitted a copy of press release dated January 04, 2007, titled Nicholas Piramal's Wellspring acquires majority stake in Jankharia Imaging to become India's First Corporate to enter into High-End Health Imaging Services" shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.